56252-09-6 Usage
Purity Level
97%
The compound has a high level of purity, indicating minimal impurities and a high-quality product.
Aromatic Properties
Strong
The compound has a strong aromatic character due to the presence of the naphthaldehyde ring structure.
Usage
Synthesis of various organic compounds
It is commonly used as an intermediate in the synthesis of a wide range of organic compounds.
Applications
Pharmaceutical, agrochemical, and dye production
The compound serves as a reagent in chemical reactions, particularly in the production of pharmaceuticals, agrochemicals, and dyes.
Molecular Structure
Unique
The compound has a unique molecular structure and functional groups, making it versatile for various industrial applications.
Handling Precautions
Hazardous if not used properly
It is important to handle this chemical with care, as it can pose risks to human health and the environment if not used according to proper safety guidelines.
Check Digit Verification of cas no
The CAS Registry Mumber 56252-09-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,6,2,5 and 2 respectively; the second part has 2 digits, 0 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 56252-09:
(7*5)+(6*6)+(5*2)+(4*5)+(3*2)+(2*0)+(1*9)=116
116 % 10 = 6
So 56252-09-6 is a valid CAS Registry Number.
InChI:InChI=1/C13H12O3/c1-15-12-7-9-5-3-4-6-10(9)11(8-14)13(12)16-2/h3-8H,1-2H3
56252-09-6Relevant articles and documents
Novel Regioselectivity under Conformational Control in the Methylation of 2,3-Dihydroxy-1-naphthaldehyde
Dean, Francis M.,El-Kass, Gassan,Prakash, Lalit
, p. 502 - 503 (1985)
Methylation of 2,3-dihydroxy-1-naphthaldehyde with iodomethane and potassium carbonate in acetone selectively etherifies the chelated 2-hydroxy group because ionisation of this destroys the stabilising hydrogen bond and allows the formyl group to take up a preferred conformation away from the reaction centre.
N-(2-phenyl-4-piperidinybutyl)-5,6,7,8-tetrahydro-1-naphthalenecarboxamides and their use as neurokinin 1 (NK1) and/or neurokinin 2 (NK2) receptor antagonists
-
, (2008/06/13)
Compounds of formula (I), wherein R2is a 5,6,7,8-tetrahydronaphth-1-yl group which may be substituted (the remaining groups defined herein), and pharmaceutical compositions containing the compounds and methods of using the compounds in the treatment of a condition where antagonism of the NK1 and/or NK2 receptors is beneficial.
